Endrika Hinton, MD
Reproductive Endocrinology · Lutherville, MDNPI 1477561579
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,130 and has fallen 93.1% since, to $78 in 2025.
Across 221 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$801
- Ferring Pharmaceuticals Inc.$498
- Exeltis, USA Inc.$433
- Therapeuticsmd, Inc.$377
- Mayne Pharma Commercial LLC$235
- Myovant Sciences Inc.$214
- plus $1K from 28 others
What the payments were for
- Food & beverage$3,89896%
- Education$1504%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $801 |
| Ferring Pharmaceuticals Inc. | 26 | $498 |
| Exeltis, USA Inc. | 24 | $433 |
| Therapeuticsmd, Inc. | 23 | $377 |
| Mayne Pharma Commercial LLC | 9 | $235 |
| Myovant Sciences Inc. | 10 | $214 |
| Evofem Biosciences, Inc. | 10 | $151 |
| Ferring Pharmaceuticals AS | 1 | $127 |
| Millicent US Inc | 7 | $107 |
| Baxter Healthcare | 3 | $100 |
| Pfizer | 4 | $85 |
| Astellas Pharma US Inc | 2 | $84 |
| Bayer | 5 | $83 |
| Organon | 4 | $75 |
| AMAG Pharmaceuticals, Inc. | 4 | $66 |
| Merck | 3 | $53 |
| Johnson & Johnson | 2 | $53 |
| Avion Pharmaceuticals | 3 | $48 |
| Agile Therapeutics, Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Acessa Health Inc. | 1 | $42 |
| Coopersurgical, Inc. | 2 | $39 |
| Hologic Sales And Service, LLC | 2 | $36 |
| Mylan Pharmaceuticals Inc. | 2 | $34 |
| Novo Nordisk | 1 | $34 |
| Lupin Inc. | 2 | $31 |
| Olympus America Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $20 |
| Shield Therapeutics Inc | 1 | $20 |
| Mission Pharmacal Company | 1 | $17 |
| Meditrina | 1 | $16 |
| Guerbet LLC | 1 | $15 |
| Conmed Corporation | 1 | $15 |
How this compares
$4,048 in reported general payments places this provider in the 75th percentile of 32 reproductive endocrinology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 31 | $3,150 |
| Estradiol | 26 | $1,740 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 11 | $1,405 |
| Estradiol (Once Weekly)Estradiol | 12 | $1,340 |
| DottiEstradiol | 14 | $912 |
| ProgesteroneProgesterone, Micronized | 26 | $864 |
Paid to pharmacies, not to this prescriber.
Other reproductive endocrinology in Lutherville
- Lauren ReschkeLutherville$904
- Billy CatherinoBethesda$140K
- Eric LevensBethesda$39K
- Jason BromerFrederick$24K
- Micah HillRockville$22K
- Jeanne ObrienRockville$15K
- Kathryn HummRockville$7K
- Isaac SassonRockville$6K
- James SegarsBaltimore$4K
- Peter LindnerBethesda$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.